[go: up one dir, main page]

DK3585892T3 - Fremgangsmåder til oprensning af messenger-rna - Google Patents

Fremgangsmåder til oprensning af messenger-rna Download PDF

Info

Publication number
DK3585892T3
DK3585892T3 DK18711737.9T DK18711737T DK3585892T3 DK 3585892 T3 DK3585892 T3 DK 3585892T3 DK 18711737 T DK18711737 T DK 18711737T DK 3585892 T3 DK3585892 T3 DK 3585892T3
Authority
DK
Denmark
Prior art keywords
purification
methods
messenger rna
messenger
rna
Prior art date
Application number
DK18711737.9T
Other languages
English (en)
Inventor
Frank Derosa
Michael Heartlein
Jonathan Abysalh
Shrirang Karve
Anusha Dias
Daniel Crawford
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Application granted granted Critical
Publication of DK3585892T3 publication Critical patent/DK3585892T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1065Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y201/00Transferases transferring one-carbon groups (2.1)
    • C12Y201/03Carboxy- and carbamoyltransferases (2.1.3)
    • C12Y201/03003Ornithine carbamoyltransferase (2.1.3.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK18711737.9T 2017-02-27 2018-02-27 Fremgangsmåder til oprensning af messenger-rna DK3585892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762463981P 2017-02-27 2017-02-27
PCT/US2018/019978 WO2018157141A1 (en) 2017-02-27 2018-02-27 Methods for purification of messenger rna

Publications (1)

Publication Number Publication Date
DK3585892T3 true DK3585892T3 (da) 2022-08-22

Family

ID=61683899

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18711737.9T DK3585892T3 (da) 2017-02-27 2018-02-27 Fremgangsmåder til oprensning af messenger-rna

Country Status (10)

Country Link
US (2) US10975369B2 (da)
EP (2) EP3585892B8 (da)
AU (1) AU2018224318B2 (da)
CA (1) CA3054323A1 (da)
DK (1) DK3585892T3 (da)
ES (1) ES2925083T3 (da)
HU (1) HUE059594T2 (da)
IL (1) IL268856B2 (da)
MA (1) MA47606A (da)
WO (1) WO2018157141A1 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3336082T3 (da) 2011-06-08 2020-04-27 Translate Bio Inc Spaltelige lipider
DK3585892T3 (da) * 2017-02-27 2022-08-22 Translate Bio Inc Fremgangsmåder til oprensning af messenger-rna
EP3668979A4 (en) 2017-08-18 2021-06-02 Modernatx, Inc. METHOD OF HPLC ANALYSIS
MA50803A (fr) 2017-11-22 2020-09-30 Modernatx Inc Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée
CA3097912A1 (en) * 2018-05-15 2019-11-21 Translate Bio, Inc. Subcutaneous delivery of messenger rna
CN118421617A (zh) 2018-08-24 2024-08-02 川斯勒佰尔公司 用于纯化信使rna的方法
PT3924487T (pt) * 2019-02-11 2024-05-31 Ethris Gmbh Purificação de arnm por filtração de fluxo tangencial
WO2020185811A1 (en) 2019-03-11 2020-09-17 Modernatx, Inc. Fed-batch in vitro transcription process
CN115461042A (zh) 2019-12-20 2022-12-09 翻译生物公司 制备负载mrna的脂质纳米颗粒的改进方法
KR20220142432A (ko) 2019-12-20 2022-10-21 트랜슬레이트 바이오 인코포레이티드 메신저 rna의 직장 전달
CA3170319A1 (en) * 2020-02-10 2021-08-19 Translate Bio, Inc. Methods and compositions for messenger rna purification
WO2021173840A1 (en) 2020-02-25 2021-09-02 Translate Bio, Inc. Improved processes of preparing mrna-loaded lipid nanoparticles
WO2021226461A1 (en) * 2020-05-07 2021-11-11 Translate Bio, Inc. Generation of optimized nucleotide sequences
US20230190954A1 (en) 2020-05-07 2023-06-22 Translate Bio, Inc. Composition and methods for treatment of primary ciliary dyskinesia
JP2023524767A (ja) 2020-05-07 2023-06-13 トランスレイト バイオ, インコーポレイテッド SARS-CoV-2抗原をコードする最適化されたヌクレオチド配列
AU2021273502A1 (en) 2020-05-15 2023-02-02 Translate Bio, Inc. Lipid nanoparticle formulations for mRNA delivery
CN117255711A (zh) * 2020-10-01 2023-12-19 翻译生物公司 用于纯化信使rna的方法
EP4225268A1 (en) 2020-10-06 2023-08-16 Translate Bio, Inc. Improved process and formulation of lipid nanoparticles
WO2022081548A1 (en) 2020-10-12 2022-04-21 Translate Bio, Inc. Improved process of preparing ice-based lipid nanoparticles
AU2021361986A1 (en) 2020-10-12 2023-06-15 Translate Bio, Inc. Improved process of preparing mrna-loaded lipid nanoparticles
JP2023546175A (ja) 2020-10-14 2023-11-01 ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド 脂質ナノ粒子製造の方法及びそれに由来する組成物
US20220136022A1 (en) 2020-10-15 2022-05-05 Translate Bio, Inc. Large Scale Synthesis of Messenger RNA
US20250268994A1 (en) 2021-03-25 2025-08-28 Translate Bio, Inc. Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof
US20250073351A1 (en) 2021-04-19 2025-03-06 Translate Bio, Inc. Improved compositions for delivery of mrna
JP2024518546A (ja) 2021-05-12 2024-05-01 ザ ブロード インスティテュート,インコーポレーテッド 修飾されたmRNA、修飾された非コードRNA、およびその使用
US20220363937A1 (en) 2021-05-14 2022-11-17 Armstrong World Industries, Inc. Stabilization of antimicrobial coatings
CN117881395A (zh) 2021-07-01 2024-04-12 翻译生物公司 用于递送mRNA的组合物
CN118591398A (zh) 2021-11-10 2024-09-03 翻译生物公司 用于治疗原发性纤毛运动不良症的组合物和方法
WO2023118571A1 (en) * 2021-12-23 2023-06-29 Quantoom Biosciences S.A. Methods and systems for capping nucleic acid
BE1030204B1 (fr) * 2022-01-20 2023-08-21 Quantoom Biosciences S A Méthodes et systèmes de coiffage de molécules d’acide nucléique
BE1030203B1 (fr) * 2022-01-20 2023-08-21 Quantoom Biosciences S A Méthodes et systèmes de coiffage de molécules d’acide nucléique
WO2023118572A1 (en) * 2021-12-23 2023-06-29 Quantoom Biosciences S.A. Methods and systems for capping nucleic acid molecules
US20250136970A1 (en) * 2022-02-03 2025-05-01 Modernatx, Inc. Continuous precipitation for mrna purification
WO2023225524A1 (en) * 2022-05-17 2023-11-23 Modernatx, Inc. Preparation of highly concentrated mrna
CA3263324A1 (en) 2022-07-29 2024-02-01 Sanofi Pasteur Inc. ETHANOL-FREE MRNA PURIFICATION PROCESSES
WO2024083345A1 (en) 2022-10-21 2024-04-25 BioNTech SE Methods and uses associated with liquid compositions
WO2024112652A1 (en) 2022-11-21 2024-05-30 Translate Bio, Inc. Compositions of dry powder formulations of messenger rna and methods of use thereof
EP4633673A1 (en) 2022-12-15 2025-10-22 Sanofi Pasteur Inc. Mrna encoding influenza virus-like particle
CN120475991A (zh) 2022-12-20 2025-08-12 赛诺菲巴斯德有限公司 鼻病毒mRNA疫苗
WO2024133884A2 (en) 2022-12-23 2024-06-27 Sanofi Optimized tailing of messenger rna
EP4677078A1 (en) 2023-03-07 2026-01-14 Sanofi Pasteur Inc. Manufacture of messenger rna with kp34 polymerase
WO2024194767A1 (en) 2023-03-17 2024-09-26 BioNTech SE Automated drug production system
WO2024218166A1 (en) 2023-04-17 2024-10-24 Sanofi Reconstitutable dry powder formulations and methods of use thereof
WO2025017151A1 (en) 2023-07-18 2025-01-23 Sanofi Stable poly(a)-encoding messenger rna templates
WO2025104351A1 (en) 2023-11-17 2025-05-22 Sanofi Pasteur Inc. Hplc-based assays for detecting multiple mrna constructs
GB202319423D0 (en) * 2023-12-18 2024-01-31 BioNTech SE Measuring and reducing protein impurities
WO2025141200A1 (en) 2023-12-29 2025-07-03 Sanofi Pasteur Inc. Modified rna polymerases
WO2025208142A2 (en) 2024-03-29 2025-10-02 New England Biolabs, Inc. Compositions, kits, and methods for in vitro transcription

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1292758A (en) 1918-04-12 1919-01-28 Roque Galguera Y Gonzalez Filtering apparatus.
US1478660A (en) 1921-01-20 1923-12-25 Barnes Gerard Charles Centrifugal separator
NL296242A (da) 1962-10-01
US3411631A (en) 1966-09-09 1968-11-19 Dorr Oliver Inc Screening centrifuges
DE1632291B1 (de) 1966-10-22 1971-07-29 Hitachi Shipbuilding Eng Co Kontinuierlich arbeitende Siebzentrifuge
US3438500A (en) 1967-05-18 1969-04-15 Francisco A Pico Centrifugal separating apparatus
US3491888A (en) 1968-12-27 1970-01-27 Universal Oil Prod Co Self-cleaning screen baskets
DE1911147A1 (de) 1969-03-05 1970-11-19 Ernst Heinkel Maschb Gmbh Zentrifuge
US3483991A (en) 1969-05-07 1969-12-16 Pennwalt Corp Screen centrifuge apparatus
US3684099A (en) 1970-07-21 1972-08-15 Carl T Kiebach Assembly element for press
DE2153901C3 (de) 1971-10-28 1979-12-20 Elfo Ag Sachseln, Sachseln (Schweiz) Siebformkörper
US3774769A (en) 1971-11-22 1973-11-27 Gaf Corp Liquid filter pressurized apparatus
DE2709894C3 (de) 1977-03-08 1982-01-07 Heinkel Industriezentrifugen GmbH & Co, 7120 Bietigheim-Bissingen Diskontinuierliche Filterzentrifuge
DE2710624C2 (de) 1977-03-11 1985-09-19 Heinkel Industriezentrifugen GmbH + Co, 7120 Bietigheim-Bissingen Stülpfilterzentrifuge
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4381236A (en) 1981-02-19 1983-04-26 Baker Perkins Inc. High pressure rotary centrifugal separator having apparatus for automatically cyclically reciprocating a corotating separator basket scraper
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US4944874A (en) 1986-12-12 1990-07-31 Kabushiki Kaisha Okawara Seisakusho Centrifugal separator
DE3740411C2 (de) 1987-11-28 1996-11-14 Heinkel Ind Zentrifugen Stülpfilterzentrifuge
DE3838108A1 (de) 1988-11-10 1990-05-17 Heinkel Ind Zentrifugen Vorrichtung zum betreiben eines auspressfilters
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
DE3916383C2 (de) 1989-05-19 1999-01-07 Guntram Krettek Vorrichtung zum Halten von Filterfolien oder Filtertüchern
US5004540A (en) 1989-12-01 1991-04-02 Ketema Process Equipment Division Invertible filter-type centrifuge with improved bearing and seal assembly
US20070053879A1 (en) * 1990-03-05 2007-03-08 Genzyme Corporation Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
DK0448737T3 (da) 1990-03-24 1994-12-12 Heinkel Ind Zentrifugen Reversibel centrifuge med filter
US5277804A (en) 1990-03-24 1994-01-11 Heinkel Industriezentrifugen Gmbh & Co. Sleeve filter centrifuge
SE9003978D0 (sv) * 1990-12-13 1990-12-13 Henrik Garoff Dna expressionssystem baserade paa ett virus replikon
ES2092136T3 (es) 1991-05-04 1996-11-16 Heinkel Ind Zentrifugen Maquina centrifugadora de filtro de inversion.
DE4230261A1 (de) 1991-10-01 1993-04-08 Krauss Maffei Ag Diskontinuierlich arbeitende filterzentrifuge
US5378364A (en) 1992-09-14 1995-01-03 Baker Hughes Incorporated Conical screen basket centrifuge
US5571669A (en) * 1993-01-14 1996-11-05 The University Of Pennsylvania Transcription and nucleic acid sequence determination with short primer DNA/RNA molecules and RNA polymerase
US5380434A (en) 1993-07-21 1995-01-10 Tema Systems, Inc. Centrifuge scroll with abrasion resistant inserts
EP0635309B1 (de) 1993-07-22 1998-01-28 Sulzer-Escher Wyss AG Doppelschubzentrifuge
US5397471A (en) 1993-08-30 1995-03-14 Tema Systems, Inc. Self-cleaning scroll and screen centrifuge
US5433849A (en) 1993-09-15 1995-07-18 Lyco Manufacturing, Inc. Double drum waste water screen
DE4337618C1 (de) 1993-11-04 1995-02-16 Krauss Maffei Ag Stülpfilterzentrifuge (Trommelraumabdichtung)
JP3256238B2 (ja) * 1994-02-11 2002-02-12 クイアジェン・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 二本鎖/単鎖核酸構造物の分離方法
EP0702690A1 (en) * 1994-04-07 1996-03-27 Akzo Nobel N.V. Freeze-dried compositions comprising rna
US6291189B1 (en) * 1994-05-10 2001-09-18 Carta Proteomics, Inc. Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides or proteins and for characterization of the fine structure of protein binding sites
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5713826A (en) 1996-05-07 1998-02-03 Waterlink, Inc. Vertical basket centrifuge with feed acceleration and a removable liner
US5874268A (en) * 1996-09-23 1999-02-23 Duke University Method of introducing exogenous compounds into cells by electroporation and apparatus for same
IT1285052B1 (it) 1996-10-18 1998-06-03 Gennaretti S P A Centrifuga orizzontale per l'estrazione di olio da un impasto oleoso
US20030083272A1 (en) * 1997-09-19 2003-05-01 Lahive & Cockfield, Llp Sense mrna therapy
US7087580B2 (en) * 1998-04-23 2006-08-08 Genesense Technologies, Inc. Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
US6811788B2 (en) * 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US6730796B2 (en) * 2000-10-16 2004-05-04 Chugai Seiyaku Kabushiki Kaisha Process for preparation of N-substituted 2-sulfanylimidazoles
DE10115381A1 (de) 2001-03-28 2002-10-24 Heinkel Ag Stülpfilterzentrifuge
US7348418B2 (en) * 2002-02-08 2008-03-25 Memorial Sloan-Kettering Cancer Center Carcinoma-related genes and polypeptides and methods of use thereof
US6736968B2 (en) 2002-06-25 2004-05-18 Tema Systems, Inc. Horizontal scroll screen centrifuge
AU2003257850A1 (en) * 2002-08-14 2004-03-03 Mitsubishi Kagaku Iatron, Inc. ANTIBODY SPECIFIC TO CENTRAL Tau-PROTEIN
DE10245013A1 (de) 2002-09-20 2004-04-01 Heinkel Aktiengesellschaft Filterzentrifuge
DE10311997A1 (de) 2003-03-19 2004-10-07 Johannes Gerteis Stülpfilterzentrifuge
WO2005016374A1 (en) * 2003-07-02 2005-02-24 Board Of Regents, The University Of Texas System Regulation of urokinase receptor expression by phosphoglycerate kinase
WO2005093052A1 (en) * 2004-03-26 2005-10-06 Fuji Photo Film Co., Ltd. Method for selectively separating and purifying rna and method for separating and purifying nucleic acid
US20050245381A1 (en) 2004-04-30 2005-11-03 National-Oilwell, L.P. Centrifuge accelerator system
DE102004032460B3 (de) * 2004-06-30 2005-08-18 Rina-Netzwerk Rna Technologien Gmbh Verfahren zur präparativen in vitro Proteinbiosynthese
FR2873596B1 (fr) 2004-07-27 2006-09-22 Weatherford Lamb Centrifugeuse avec une bride de serrage crantee
US20070066552A1 (en) * 2005-01-21 2007-03-22 Introgen Therapeutics, Inc. Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
US20080149558A1 (en) 2006-12-21 2008-06-26 Ferrum Ag Centrifuge drum
US8257587B2 (en) 2007-04-05 2012-09-04 Ludowici Australia Pty. Ltd. Centrifugal scroll screen apparatus
CA3006395C (en) 2008-11-07 2022-05-31 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US8021289B2 (en) 2009-02-20 2011-09-20 Tema Systems, Inc. Clean-in-place decanter centrifuge
US20100326827A1 (en) * 2009-06-24 2010-12-30 Shang-Chi Lin Method and apparatus for isolating and purifying bio-molecules
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
CA2781897C (en) 2009-11-27 2018-02-20 Arrowcorp Inc. Cylinder exchange device and method for solid material processor
HUE038039T2 (hu) 2009-12-01 2018-09-28 Translate Bio Inc mRNS bejuttatása fehérjék és enzimek kiegészítésére humán genetikai betegségekben
WO2012075040A2 (en) 2010-11-30 2012-06-07 Shire Human Genetic Therapies, Inc. mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
DK3336082T3 (da) 2011-06-08 2020-04-27 Translate Bio Inc Spaltelige lipider
ME03491B (me) * 2011-06-08 2020-01-20 Translate Bio Inc Kompozicije lipidnih nanočestica i postupci za isporuku irnk
KR20150000461A (ko) 2011-10-27 2015-01-02 메사추세츠 인스티튜트 오브 테크놀로지 약물 캡슐화 마이크로스피어를 형성할 수 있는, n-말단 상에 관능화된 아미노산 유도체
EP2791159A4 (en) * 2011-12-14 2015-10-14 Moderna Therapeutics Inc MODIFIED NUCLEIC ACIDS AND ACUTE TREATMENT USES THEREOF
US20130156849A1 (en) * 2011-12-16 2013-06-20 modeRNA Therapeutics Modified nucleoside, nucleotide, and nucleic acid compositions
US9933343B2 (en) * 2012-03-14 2018-04-03 Chromologic Llc Integrated membrane for preservation of biomolecules
DK2830595T3 (da) 2012-03-29 2019-12-02 Translate Bio Inc Ioniserbare kationiske lipider
JP6211054B2 (ja) 2012-03-29 2017-10-11 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 脂質誘導される中性ナノ粒子
US10501513B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides for the production of oncology-related proteins and peptides
HK1206601A1 (en) * 2012-04-02 2016-01-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
EP2859102A4 (en) 2012-06-08 2016-05-11 Shire Human Genetic Therapies NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF
BR112014030677A2 (pt) 2012-06-08 2022-07-19 Shire Human Genetic Therapies distribuição pulmonar de mrna para células-alvo não-pulmonares
US10913015B2 (en) 2012-09-14 2021-02-09 Aqseptence Group, Inc. Variable geometry centrifugal basket
US20150366997A1 (en) 2012-12-07 2015-12-24 Shire Human Genetics Therapies, Inc. COMPOSITIONS AND METHODS FOR mRNA DELIVERY
EP3467108B1 (en) 2013-03-14 2024-05-22 Translate Bio, Inc. Methods for purification of messenger rna
BR112015022505A2 (pt) 2013-03-14 2017-10-24 Shire Human Genetic Therapies avaliação quantitativa para eficiência do cap de rna mensageiro
ES2882110T3 (es) 2013-03-14 2021-12-01 Translate Bio Inc Métodos y composiciones para administrar anticuerpos codificados con ARNm
EA037922B1 (ru) 2013-03-14 2021-06-07 Шир Хьюман Дженетик Терапис, Инк. мРНК CFTR И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ МУКОВИСЦИДОЗА У МЛЕКОПИТАЮЩЕГО
EP3301102B1 (en) 2013-03-14 2020-04-15 Translate Bio, Inc. Ribonucleic acids with 4'-thio-modified nucleotides and related methods
US10258698B2 (en) * 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
MX2015011945A (es) 2013-03-14 2015-12-01 Shire Human Genetic Therapies Evaluacion cuantitativa para la eficacia de los casquetes de arn mensajero.
ES2692363T3 (es) 2013-03-14 2018-12-03 Translate Bio, Inc. Composiciones terapéuticas de ARNm y su uso para tratar enfermedades y trastornos
WO2014144767A1 (en) * 2013-03-15 2014-09-18 Moderna Therapeutics, Inc. Ion exchange purification of mrna
CN104236289B (zh) 2013-06-06 2016-03-23 富泰华工业(深圳)有限公司 脱水装置
MX2016005238A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Formulaciones de lipidos para la administracion de acido ribonucleico mensajero.
AU2014340092B2 (en) 2013-10-22 2019-09-19 Translate Bio, Inc. mRNA therapy for Argininosuccinate Synthetase Deficiency
EP3060671B1 (en) 2013-10-22 2021-12-29 Translate Bio, Inc. Cns delivery of mrna and uses thereof
EP3060258A1 (en) 2013-10-22 2016-08-31 Shire Human Genetic Therapies, Inc. Mrna therapy for phenylketonuria
US9534214B2 (en) * 2013-10-31 2017-01-03 General Electric Company Substrates and associated methods for elution of nucleic acids
US20170056526A1 (en) * 2014-02-26 2017-03-02 Ethris Gmbh Compositions for gastrointestinal administration of rna
EP3450553B1 (en) 2014-03-24 2019-12-25 Translate Bio, Inc. Mrna therapy for treatment of ocular diseases
EP3636742B1 (en) * 2014-04-25 2025-11-05 Translate Bio, Inc. Methods for purification of messenger rna
CA2949106C (en) 2014-05-30 2023-10-24 Shire Human Genetic Therapies, Inc. Biodegradable lipids for delivery of nucleic acids
EA033966B1 (ru) 2014-06-24 2019-12-13 Транслейт Био, Инк. Стереохимически обогащенные композиции для доставки нуклеиновых кислот
CN106456547B (zh) 2014-07-02 2021-11-12 川斯勒佰尔公司 信使rna的包封
EP3177732A4 (en) * 2014-08-08 2018-04-25 ModernaTX, Inc. Compositions and methods for the treatment of ophthalmic diseases and conditions
US10717091B2 (en) 2014-08-14 2020-07-21 Aqseptence Group, Inc. Batch centrifuge filter screen
DE102014119605A1 (de) 2014-12-23 2016-06-23 Andritz Kmpt Gmbh Filterzentrifuge
US10293348B2 (en) 2015-01-15 2019-05-21 Weir Minerals Australia Ltd Centrifugal scroll screen apparatus
AU2015376856B2 (en) 2015-01-15 2021-03-11 Weir Minerals Australia Ltd Centrifugal scroll screen apparatus
WO2016112426A1 (en) 2015-01-15 2016-07-21 Weir Minerals Australia Ltd Centrifugal screening apparatus
AU2016233135B2 (en) 2015-03-19 2021-07-08 Translate Bio, Inc. mRNA therapy for pompe disease
ES2798271T3 (es) 2015-05-29 2020-12-10 Curevac Real Estate Gmbh Método para producir y purificar ARN, que comprende al menos una etapa de filtración de flujo tangencial
WO2017009376A1 (en) * 2015-07-13 2017-01-19 Curevac Ag Method of producing rna from circular dna and corresponding template dna
SI3350333T1 (sl) * 2015-09-17 2022-04-29 ModernaTX,Inc. Polinukleotidi, ki zajemajo stabilizacijsko repno regijo
WO2017049074A1 (en) * 2015-09-18 2017-03-23 Moderna Therapeutics, Inc. Polynucleotide formulations for use in the treatment of renal diseases
DK3585892T3 (da) * 2017-02-27 2022-08-22 Translate Bio Inc Fremgangsmåder til oprensning af messenger-rna

Also Published As

Publication number Publication date
EP4008783A1 (en) 2022-06-08
EP3585892B1 (en) 2022-06-01
US12410422B2 (en) 2025-09-09
AU2018224318B2 (en) 2024-06-20
HUE059594T2 (hu) 2022-11-28
US20210180041A1 (en) 2021-06-17
EP3585892A1 (en) 2020-01-01
EP3585892B8 (en) 2022-07-13
IL268856A (en) 2019-10-31
IL268856B2 (en) 2024-09-01
WO2018157141A1 (en) 2018-08-30
ES2925083T3 (es) 2022-10-13
IL268856B1 (en) 2024-05-01
US20180251754A1 (en) 2018-09-06
AU2018224318A1 (en) 2019-09-19
MA47606A (fr) 2021-04-07
CA3054323A1 (en) 2018-08-30
US10975369B2 (en) 2021-04-13

Similar Documents

Publication Publication Date Title
DK3585892T3 (da) Fremgangsmåder til oprensning af messenger-rna
DK3585891T3 (da) Fremgangsmåder til oprensning af messenger-rna
DK3636742T3 (da) Fremgangsmåder til oprensning af messenger-rna
DK3585886T3 (da) Storskalasyntese af messenger-rna
DK4140491T5 (da) Fremgangsmåde til syntetisering af RNA'er med 5'-kappe
DK3467108T3 (da) Fremgangsmåder til oprensning af messenger-RNA
IL263690A (en) Purification of multispecific antibodies
DK3268390T3 (da) Fremgangsmåder til oprensning af bispecifikke antistoffer
DK3445850T3 (da) Fremgangsmåder til tilvejebringelse af enkeltstrenget rna
DK3377059T3 (da) Hæmmere af cxcr2
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3337902T3 (da) 3'-utr-sekvenser til stabilisering af rna
EP3349649A4 (en) NAVIGATION OF TUBULAR NETWORKS
DK3294885T3 (da) Fremgangsmåde til at fremstille rna
DK3463483T3 (da) Behandling af primær ciliedyskinesi med syntetisk messenger-RNA
DK3113858T3 (da) Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
DK3201361T3 (da) Fremgangsmåder til kvantificering af cellefrit DNA
DK3607068T3 (da) RNA-interferensmedieret inhibering af TMPRSS6
DK3510042T3 (da) Fremgangsmåde til rensning af antistoffer
DK3609529T3 (da) Rna til behandling af autoimmune sygdomme
DK3665173T3 (da) Ny fremgangsmåde til yntetisering af amanitiner
DK3356386T3 (da) Fremgangsmåde til behandling af melanocortin-4 receptorbane-associerede lidelser
DK3680000T3 (da) Fremgangsmåder til oprensning af antistoffer
DK3347481T3 (da) Fremgangsmåde til oprensning af biomassehydrolysat
DK3307878T3 (da) Fremgangsmåder til fremstilling og oprensning af nukleinsyreholdige sammensætninger